ATE283479T1 - Verfahren und testsatz zur bestimmung der analytkonzentration im blut - Google Patents

Verfahren und testsatz zur bestimmung der analytkonzentration im blut

Info

Publication number
ATE283479T1
ATE283479T1 AT99938497T AT99938497T ATE283479T1 AT E283479 T1 ATE283479 T1 AT E283479T1 AT 99938497 T AT99938497 T AT 99938497T AT 99938497 T AT99938497 T AT 99938497T AT E283479 T1 ATE283479 T1 AT E283479T1
Authority
AT
Austria
Prior art keywords
blood
determining
analyte
test set
analyte concentration
Prior art date
Application number
AT99938497T
Other languages
English (en)
Inventor
Falk Fish
Original Assignee
Falk Fish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Falk Fish filed Critical Falk Fish
Application granted granted Critical
Publication of ATE283479T1 publication Critical patent/ATE283479T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99938497T 1998-08-21 1999-08-19 Verfahren und testsatz zur bestimmung der analytkonzentration im blut ATE283479T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12588098A IL125880A (en) 1998-08-21 1998-08-21 Method for the determination of analyte concentration in blood
PCT/IL1999/000447 WO2000011469A1 (en) 1998-08-21 1999-08-19 Method and kit for the determination of analyte concentration in blood

Publications (1)

Publication Number Publication Date
ATE283479T1 true ATE283479T1 (de) 2004-12-15

Family

ID=11071875

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938497T ATE283479T1 (de) 1998-08-21 1999-08-19 Verfahren und testsatz zur bestimmung der analytkonzentration im blut

Country Status (8)

Country Link
US (1) US7060453B1 (de)
EP (1) EP1105727B1 (de)
JP (1) JP2002523744A (de)
AT (1) ATE283479T1 (de)
AU (1) AU5300199A (de)
DE (1) DE69922213T2 (de)
IL (1) IL125880A (de)
WO (1) WO2000011469A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL138788A0 (en) * 2000-09-29 2001-10-31 Falk Fish Method and kit for the transdermal determination of analyte concentration in blood
US20070156345A1 (en) * 2005-12-30 2007-07-05 Hyde Roderick A Modulating a biological recording with another biological recording
US8150628B2 (en) 2005-12-30 2012-04-03 The Invention Science Fund I, Llc Establishing a biological recording timeline by artificial marking
TW200801513A (en) * 2006-06-29 2008-01-01 Fermiscan Australia Pty Ltd Improved process
US8986939B1 (en) 2013-08-28 2015-03-24 Psychemedics Corporation Integrity testing of hair samples

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS175782B1 (de) 1974-10-16 1977-05-31
CS176664B1 (de) 1975-02-14 1977-06-30
US4615982A (en) 1984-12-11 1986-10-07 Lawrence Paul J Fecal occult blood test
US5362307A (en) * 1989-01-24 1994-11-08 The Regents Of The University Of California Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
US5056521A (en) * 1989-06-29 1991-10-15 Health Craft International, Inc. Method for monitoring glucose level
US5103836A (en) * 1990-02-28 1992-04-14 Epitope, Inc. Oral collection device and kit for immunoassay
US5089420A (en) * 1990-01-30 1992-02-18 Miles Inc. Composition, device and method of assaying for a peroxidatively active substance utilizing amine borate compounds
US5268148A (en) 1990-12-18 1993-12-07 Saliva Diagnostic Systems, Inc. Saliva sampling device and sample adequacy system
US5714341A (en) * 1994-03-30 1998-02-03 Epitope, Inc. Saliva assay method and device
US6102872A (en) 1997-11-03 2000-08-15 Pacific Biometrics, Inc. Glucose detector and method

Also Published As

Publication number Publication date
IL125880A0 (en) 1999-04-11
JP2002523744A (ja) 2002-07-30
WO2000011469A1 (en) 2000-03-02
US7060453B1 (en) 2006-06-13
DE69922213D1 (de) 2004-12-30
AU5300199A (en) 2000-03-14
DE69922213T2 (de) 2005-11-24
EP1105727A1 (de) 2001-06-13
EP1105727B1 (de) 2004-11-24
IL125880A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
DE60317422D1 (de) Mediator-stabilisierende Verbindung und Methoden zur Verwendung zur Detektion elektrochemischer Analyte
MY133942A (en) Reagent test strip for analyte determination having hemolyzing agent
WO2002027326A3 (en) Method and kit for the transderaml determination of analyte concentration in blood
ATE133453T1 (de) Verfahren zur bestimmung von glukose in vollblut sowie gefäss und fotometer zur durchführung dieses verfahrens
ATE257595T1 (de) Wegwerfbare teststreifen zur bestimmung von blutbestandteilen und verfahren zur herstellung derselben
GB2321967A (en) Opaque reaction matrix for the analysis of whole blood
EP1234053A4 (de) Vorrichtung und verfahren zum bestimmen der koagulation in flüssigproben
DE59710488D1 (de) Vorrichtung und Verwendung einer Vorrichtung zur Bestimmung der Konzentration von Hämoglobinderivaten in einer unverdünnten, unhämolysierten Vollblutprobe
DE69419192T2 (de) Methode zur Bestimmung von Hämoglobinaddukten
DE69941044D1 (de) Methoden, Apparat und Computerprogramm zur quantitativen Bestimmung von Nukleinsäurensequenzen in Proben unter Verwendung von Standardkurven und Abschätzungen von Amplifikationsverhältnissen
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
ATE333091T1 (de) Verfahren zur messung von blutersatzstoffen
ATE283479T1 (de) Verfahren und testsatz zur bestimmung der analytkonzentration im blut
ATE208899T1 (de) Verfahren zur analyse hämoglobin enthaltender medizinischer proben
ATE135746T1 (de) Enzymatisches verfahren zur bestimmung der analyt-konzentration
ATE208894T1 (de) Graphit-vliese als funktionelle schichten in diagnostischen testkits
DE3782715D1 (de) Verfahren zur bestimmung des konzentrationsverhaeltnisses von lithiumionen zu natriumionen und vorrichtung zur durchfuehrung dieses verfahrens.
JP2002523744A5 (de)
DE69614374T2 (de) Verfahren zur spektralanalyse von inhomogenen proben
ATE208505T1 (de) Verfahren und reagenz zur überwachung des blutspiegels von antiplättchen-verbindungen
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
ATE261120T1 (de) Anhand der konduktivität normalisierte bestimmung von analyten in urin zur diagnose von krankheiten
CA2198731A1 (en) Assay and reagent kit for the quantitative in vitro determination in biological specimens of the activity of proteins causing multi-drug resistance in tumors
SI0746767T1 (en) Analyzer cuvette, method and diagnostic test kit for determination of analytes in whole blood samples
IT1182220B (it) Metodo di dosaggio di enzimi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties